Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: J Adolesc Health. 2020 Jan 19;66(5):536–544. doi: 10.1016/j.jadohealth.2019.11.306

Table 2.

Prevalence of specific types of opioids used among adolescents aged 12-17 with past-year prescription opioid use: by use status

Adolescents with Rx opioid use or misuse
(N=8,260)
Adolescents with Rx opioid
use (N=6,754)
Adolescents with Rx
opioid misuse (N=1,506)
Past-year use or misuse of pain reliever products, % (95% CI)
 Hydrocodone 26.17 (24.82-27.53) 22.08 (20.52-23.64) 44.94 (41.39-48.49)
 Oxycodone 18.96 (18.00-19.92) 14.81 (13.69-15.94) 37.96 (34.70-41.23)
 Tramadol 7.95 (7.21-8.70) 6.42 (5.70-7.14) 14.96 (12.76-17.17)
 Morphine 8.13 (7.30-8.95) 7.44 (6.56-8.33) 11.25 (9.30-13.20)
 Fentanyl 1.17 (0.86-1.47) 0.91 (0.56-1.25) 2.36 (1.27-3.46)
 Buprenorphine 1.33 (1.04-1.63) 0.87 (0.55-1.18) 3.46 (2.29-4.64)
 Oxymorphone 1.64 (1.32-1.97) 0.98 (0.68-1.27) 4.69 (3.35-6.03)
 Demerol 0.79 (0.60-0.98) 0.72 (0.51-0.92) 1.13 (0.59-1.68)
 Hydromorphone 0.75 (0.49-1.02) 0.50 (0.27-0.73) 1.91 (0.89-2.93)
 Methadone 0.94 (0.68-1.21) 0.38 (0.21-0.56) 3.50 (2.23-4.77)
 Othera 44.44 (43.15-45.74) 44.66 (43.22-46.09) 43.47 (40.15-46.79)
 Codeineb 20.89 (19.63-22.15) 18.93 (17.59-20.26) 29.90 (27.41-32.39)
  Missing (n, %) 3,109 (38.79%) 2,569 (38.99%) 540 (37.87%)
Number of categories of pain reliever products used, % (95% CI)1
 1 59.31 (58.08-60.54) 63.58 (62.13-65.04) 39.71 (36.61-42.82)
 2 17.23 (15.96-18.50) 15.57 (14.29-16.86) 24.82 (22.36-27.28)
 3 or more 10.34 (9.59-11.08) 6.64 (5.89-7.39) 27.25 (24.77-29.73)
 missing (n, %) 1,050 (13.13%) 948 (14.20%) 102 (8.21%)
Frequency of opioid misuse in past month, % (95% CI)
 1-2 days 2.68 (2.22-3.15) - 14.98 (12.63-17.33)
 3-5 days 1.46 (1.13-1.78) - 8.13 (6.33-9.94)
 6-19 days 0.88 (0.60-1.17) - 4.93 (3.40-6.45)
 20-30 days 0.19 (0.09-0.28) - 1.04 (0.50-1.58)
 Non user or No past-month misuse 94.79 (94.20-95.38) 100 70.92 (68.20-73.63)
Mean of days misusing opioids in the past month, Mean (95% CI)2
4.55 (3.89-5.21) N/A 4.55 (3.89-5.21)

Note. The sample size is unweighted, and all results are weighted estimates.

a

Any other prescription pain relievers: In addition to the specific prescription opioids, the NSDUH asked about any use of other prescription pain relievers.

b

Questionnaire changes since 2016: Any past-year Codeine products includes any past-year use of Codeine, Tylenol with Codeine 3 or 4, or past-year misuse of other pain relievers that contain codeine.

1

The results are based on individuals with the information available about pain reliever products used: Rx opioid users or misusers (n=7,210), Rx opioid users (n=5,806), and Rx opioid misusers (n=1,404).

2

The results are based on individuals with the information available about opioid misuse in the past month: Rx opioid users or misusers (n=436) and Rx opioid misusers (n=436).